PSTV 8-K: Smart Summary

Plus Therapeutics, Inc. (PSTV) disclosed that a Nasdaq Hearings Panel granted the company continued listing on Nasdaq, subject to the company demonstrating compliance with minimum stockholders' equity and minimum bid price requirements by specified deadlines.

• On June 3, 2025, Nasdaq notified the company of non-compliance with Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders' equity
• Company reported stockholders' equity (deficit) of ($23,641,000) as of March 31, 2025, failing the Minimum Stockholders' Equity Requirement
• Company requested a hearing; hearing took place on July 15, 2025
• On July 22, 2025, the Hearings Panel granted continued listing subject to two conditions: (1) demonstrating compliance with the Minimum Stockholders' Equity Requirement by August 14, 2025 via public disclosure of transactions undertaken to achieve and sustain compliance; and (2) achieving a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days on or before September 8, 2025